Patient-derived iPSC models of Friedreich ataxia: a new frontier for understanding disease mechanisms and therapeutic application
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Patient-derived iPSC models of Friedreich ataxia: a new frontier for understanding disease mechanisms and therapeutic application ; volume:12 ; number:1 ; day:20 ; month:9 ; year:2023 ; pages:1-23 ; date:12.2023
Translational neurodegeneration ; 12, Heft 1 (20.9.2023), 1-23, 12.2023
- Creator
-
Maheshwari, Saumya
Vilema-Enríquez, Gabriela
Wade-Martins, Richard
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40035-023-00376-8
- URN
-
urn:nbn:de:101:1-2024020112280036352605
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Maheshwari, Saumya
- Vilema-Enríquez, Gabriela
- Wade-Martins, Richard
- SpringerLink (Online service)
Other Objects (12)
Myogenesis defects in a patient-derived iPSC model of hereditary GNE myopathy
Autonomic function testing in Friedreich’s ataxia
Current Landscape of iPSC Haplobanks
FRIEDREICH ATAXIA – A CASE REPORT
Auditory Phenotypic Variability in Friedreich’s Ataxia Patients
Human iPSC banking: barriers and opportunities
Correction: Current Landscape of iPSC Haplobanks
Modeling mitochondrial disorders of the Leigh syndrome spectrum using human patient-derived cells and iPSC technology
Is Friedreich ataxia an epigenetic disorder?
Hepatic mitochondrial dysfunction in Friedreich Ataxia
A new patient‐derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α‐dystroglycan
IGF-1 in Friedreich’s Ataxia – proof-of-concept trial
Myogenesis defects in a patient-derived iPSC model of hereditary GNE myopathy
Autonomic function testing in Friedreich’s ataxia
Current Landscape of iPSC Haplobanks
FRIEDREICH ATAXIA – A CASE REPORT
Auditory Phenotypic Variability in Friedreich’s Ataxia Patients
Human iPSC banking: barriers and opportunities
Correction: Current Landscape of iPSC Haplobanks
Modeling mitochondrial disorders of the Leigh syndrome spectrum using human patient-derived cells and iPSC technology
Is Friedreich ataxia an epigenetic disorder?
Hepatic mitochondrial dysfunction in Friedreich Ataxia
A new patient‐derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α‐dystroglycan
IGF-1 in Friedreich’s Ataxia – proof-of-concept trial
Myogenesis defects in a patient-derived iPSC model of hereditary GNE myopathy
Autonomic function testing in Friedreich’s ataxia
Current Landscape of iPSC Haplobanks
FRIEDREICH ATAXIA – A CASE REPORT
Auditory Phenotypic Variability in Friedreich’s Ataxia Patients
Human iPSC banking: barriers and opportunities
Correction: Current Landscape of iPSC Haplobanks
Modeling mitochondrial disorders of the Leigh syndrome spectrum using human patient-derived cells and iPSC technology
Is Friedreich ataxia an epigenetic disorder?
Hepatic mitochondrial dysfunction in Friedreich Ataxia
A new patient‐derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α‐dystroglycan